REDAPT Anteverted Cemented Liner
K号: K160923 · 2016-11-17
广告
器械摘要
常见问题
What is the REDAPT Anteverted Cemented Liner?
REDAPT Anteverted Cemented Liner is a medical device that received FDA 510(k) clearance on 2016-11-17. The listed applicant is Smith & Nephew, Inc.. The 510(k) number is K160923.
When did REDAPT Anteverted Cemented Liner receive FDA 510(k) clearance?
REDAPT Anteverted Cemented Liner received FDA 510(k) clearance on 2016-11-17, under 510(k) number K160923.
Who is the listed applicant for REDAPT Anteverted Cemented Liner?
The FDA 510(k) record lists Smith & Nephew, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for REDAPT Anteverted Cemented Liner?
The FDA product code for REDAPT Anteverted Cemented Liner is JDI.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
列明Smith & Nephew, Inc.为申报人的其他记录
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
相关器械(代码:JDI)
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。
广告